4:14 PM ET
8-K
Stock Plan Amendment
Regeneron Pharmaceuticals Stock Plan Amendment
Regeneron granted one-time, 10-year performance share units (PSUs) to its CEO and CSO, which replace their annual equity awards through 2036. The awards are 100% performance-based, tied to ambitious pipeline milestones and new product annual revenue targets of up to $30 billion. All earned shares are subject to a mandatory holding period and cannot be sold until February 2036.
- Term
- 10 years